Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118930) titled 'Study of Sivelestat Sodium in OPCABG' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Affiliated Hospital of Nantong University

Condition: Coronary Heart Disease Coronary Artery Disease Coronary Arterial Disease (CAD)

Intervention: Drug: Sivelestat Sodium injection 2 h after OPCABG for 72 h

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: August 1, 2025

Target Sample Size: 62

Countries o...